positive phase 2a pancreatic cancer trial news. hoped for a biotech runner. Reviewed: not really a good entrance. i guess i thought it could keep above 5.00 it was already extended 100% at time of entry. cut before it got worse. loss 1.5R. i dont think i was that prepared.
| Date | Price | |
|---|---|---|
| Entry | 1/7/2025 | 4.9895 |
| Exit | 1/7/2025 | 4.60 |
- Total Views11
- Position Size25
- Percentage-7.81%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
